x

Posted 05 April, 2021

CHF Solutions, Inc. appointed new CEO

CEO Change detected for ticker Nasdaq:NUWE in a 8-K filed on 05 April, 2021.


  On April 5, 2021, the Board of Directors (the "Board") of the Company appointed Nestor Jaramillo, Jr., the Company's President and Chief Executive Officer, as the interim Chief Financial Officer and the interim Principal Financial Officer.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of CHF Solutions, Inc.
Health Care/Life Sciences • Medical Equipment/Supplies
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
Market Cap
$3.39M
View Company Details
CHF Solutions, Inc. by TradingView
Relevant filing section
Item 5.02 
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On April 1, 2021, Claudia Drayton notified CHF Solutions, Inc., a Delaware corporation (the "Company") of her decision to resign as the Chief Financial Officer of the Company. Ms. Drayton's last date with the Company is expected to be April 16, 2021. Ms. Drayton's resignation is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies, or procedures. The Company will commence a formal search process for the position of Chief Financial Officer for the Company.


On April 5, 2021, the Board of Directors (the "Board") of the Company appointed Nestor Jaramillo, Jr., the Company's President and Chief Executive Officer, as the interim Chief Financial Officer and the interim Principal Financial Officer. Mr. Jaramillo, age 63, has served as the Company's President and Chief Executive Officer since January 2021.


There is no arrangement or understanding between Mr. Jaramillo and any other person pursuant to which Mr. Jaramillo was selected as an officer. Mr. Jaramillo has no family relationships with any of the Company's directors or executive officers. There are no transactions and no proposed transactions between Mr. Jaramillo and the Company that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K.


On April 5, 2021, the Board appointed Paul Wotta as the Company's interim Principal Accounting Officer. Mr. Wotta, age 64, has served as the Company's Corporate Controller since December 2011. Previously, Mr. Wotta served as the Divisional Controller at Cenveo, Inc. from August 2010 to December 2011. Mr. Wotta holds a B.S. in Accounting from St. John's University and is a Certified Public Accountant (inactive).


There is no arrangement or understanding between Mr. Wotta and any other person pursuant to which Mr. Wotta was selected as an officer. Mr. Wotta has no family relationships with any of the Company's directors or executive officers. There are no transactions and no proposed transactions between Mr. Wotta and the Company that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K.